News Archive

Every report the desk has filed, searchable by full text, topic, format, symbol and date range.

Filtering:BSEM

Lyntris Debut Prices Soft at $1.8 Billion as Mercury Systems Punished Despite Earnings Bright Spots

A cool New York listing and a negative reaction to broadly constructive defence-electronics results underline a market rewarding cash generation over narrative in the closing weeks of the quarter

Lyntris closed its New York debut valued at $1.8 billion after shares fell from their offer level, a discouraging signal for the primary calendar. Separately, Mercury Systems declined sharply even though its earnings report contained several positive elements, with investors focused on forward-looking concerns rather than the reported quarter.

BREAKING STORYBEARISH19 Aug 2026

M&A and Deals EarningsMRCY MSI PMGC BSEM LUCY+1Read report →

Zipalertinib Hits Primary Endpoint in Lung Cancer Trial as Biotech Catalyst Season Delivers Mixed Reads

Positive pivotal data in EGFR exon 20 lung cancer lands alongside Definium's Phase 3 Voyage topline in generalized anxiety disorder and a dense slate of clinical-stage earnings calls from Allogene and Inovio.

Zipalertinib met its primary endpoint in a lung cancer study, delivering a clean pivotal readout into an unusually crowded biotech catalyst window that also featured Definium Therapeutics' Phase 3 Voyage results for DT120 and quarterly updates from Allogene and Inovio.

BREAKING STORYBULLISH13 Aug 2026

Earnings Healthcare & PharmaALLO INO BSEM XBIRead report →

Most covered symbols

GSPC NVDA TNX GOOGL BTC-USD IXIC MU AAPL CL=F TLT AMD BABA COIN CRWV GLD META MSFT NDX 000660.KS MSTR NBIS TSLA RKLB SNDK STOXX STOXX50E AMZN AVGO BRK.B BTC PLTR SMCI WMT XOM N225 BRK.A BZ=F DX-Y.NYB GC=F HOOD

Each chip opens the Research terminal for that symbol, where its archive coverage is listed alongside the fundamentals.